DoximityDOCS
DOCS
About: Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
Employees: 827
0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 13 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
100% more funds holding in top 10
Funds holding in top 10: 2 [Q2] → 4 (+2) [Q3]
47% more capital invested
Capital invested by funds: $3.37B [Q2] → $4.95B (+$1.58B) [Q3]
37% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 52
23% more call options, than puts
Call options by funds: $99M | Put options by funds: $80.6M
6% more funds holding
Funds holding: 327 [Q2] → 346 (+19) [Q3]
7.11% less ownership
Funds ownership: 97.92% [Q2] → 90.81% (-7.11%) [Q3]
28% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 129
Research analyst outlook
13 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$41
29%
downside
Avg. target
$55
4%
downside
High target
$75
30%
upside
13 analyst ratings
3 positive
23%
10 neutral
77%
0 negative
0%
Stephens & Co. Jeff Garro 43% 1-year accuracy 3 / 7 met price target | 5%downside $55 | Equal-Weight Initiated | 20 Dec 2024 |
Mizuho Steven Valiquette 20% 1-year accuracy 1 / 5 met price target | 5%downside $55 | Neutral Initiated | 4 Dec 2024 |
JP Morgan Anne Samuel 41% 1-year accuracy 14 / 34 met price target | 17%downside $48 | Neutral Maintained | 21 Nov 2024 |
Goldman Sachs David Roman 54% 1-year accuracy 7 / 13 met price target | 0%upside $58 | Neutral Initiated | 15 Nov 2024 |
Truist Securities Jailendra Singh 14% 1-year accuracy 5 / 35 met price target | 15%downside $49 | Hold Maintained | 14 Nov 2024 |
Financial journalist opinion
Based on 7 articles about DOCS published over the past 30 days
Positive
Investors Business Daily
18 hours ago
This Health Care Software Firm Nears Buy Point After Whopping 101% Year-To-Date Gain
Doximity stock jumped over 34% following its most recent earnings report on Nov. 11. Now, shares are nearing a buy point.
Neutral
GlobeNewsWire
1 day ago
DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (NYSE: DOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022, to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.
Neutral
Business Wire
4 days ago
Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its State of Telemedicine Report, showing that 83% of physician telemedicine users surveyed would like virtual care to remain a permanent part of their clinical practice. Among physicians surveyed, 84% highlighted telemedicine's value in improving continuity of care for patients with chronic or complex conditions, and 96% emphasized its role as a complement to.
Positive
Zacks Investment Research
4 days ago
Prescription for Profits: 3 Must-Buy Healthcare Stocks Before 2025
The healthcare sector is undergoing significant changes, with technology, innovation and a patient-centric approach as the cornerstones of its growth.
Positive
Seeking Alpha
2 weeks ago
Doximity: Strong Fundamentals And Growth Potential Makes It Attractive
Doximity's dominance in digital healthcare is evident with over 80% of U.S. doctors using the platform, driving strong network effects and competitive positioning. The company boasts impressive financials, with earnings surpassing expectations, strong cash reserves, and high margins, indicating robust scalability and efficiency. New AI-powered features and product launches enhance clinical workflows, while leadership's proven track record supports continued market expansion and service broadening.
Positive
Zacks Investment Research
2 weeks ago
Buy 5 High-Flying Health & Fitness Stocks of 2024 With More Upside
Five Health & Fitness stocks have strong growth potential for 2025. These are GRMN, SFM, DOCS, PLNT and PTON.
Negative
Zacks Investment Research
2 weeks ago
Are Medical Stocks Lagging Doximity (DOCS) This Year?
Here is how Doximity (DOCS) and AxoGen (AXGN) have performed compared to their sector so far this year.
Positive
Zacks Investment Research
1 month ago
3 Momentum Anomaly Stocks to Buy as Election Rally Fizzles
DOCS, PI and INOD are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
Positive
Zacks Investment Research
1 month ago
Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks
Top-ranked stocks Amazon.com (AMZN), Maplebear Inc. (CART), Exelixis (EXEL) and Doximity (DOCS) are likely to beat on the bottom line in their upcoming releases.
Positive
Zacks Investment Research
1 month ago
Surging Earnings Estimates Signal Upside for Doximity (DOCS) Stock
Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Charts implemented using Lightweight Charts™